Contact Us
Posted: July 6, 2020
  • Company News

Abingdon Health appoints Oliver Gardner at Chief Operating Officer

Former army officer and Abingdon Health Chief Operating Officer, Olly GardnerAbingdon Health is delighted to announce the appointment of Olly Gardner as Chief Operating Officer.

Olly has a wealth of leadership experience from his successful 17-year career as an Army Officer. Initially training at the Royal Military Academy Sandhurst, Olly commissioned into the Royal Signals where he reached the rank of Lieutenant Colonel. Olly led British and Gurkha soldiers in many locations across the world, before culminating his military service in the Ministry of Defence, where he worked closely with US Department of Defense leading a number of special projects.

Post Army, Olly has held senior industry roles at RWE npower and York-based Park Leisure. During his time at Park Leisure, Olly held numerous executive appointments, including Chief Operating Officer. Olly’s people focused strategies here, led to a significant improvement in the operational performance of the business. At RWE npower Olly led the customer experience transformation programme that focused on putting the customer at the heart of the company’s decision making. Olly also set up npower’s Operational Readiness team that worked closely with Legal, Regulatory and Compliance teams, to drive operational change into the business.

Olly’s role at Abingdon Health will focus on leading the Company’s exciting growth plans in operations, quality & regulatory, technology and people. Olly will report into CEO, Chris Yates.

This appointment is during an exciting time for Abingdon Health, who are leading the UK-RTC consortium in the development of a point of care COVID-19 Antibody test for the UK Government. Abingdon Health announced on 29th June 2020 that the UK-RTC product had reached design freeze, a critical milestone. Abingdon Health also announced on 17th June 2020 a significant increase in their manufacturing capacity with two new automated manufacturing lines that make the company the leading European rapid test manufacturer.

Chris Yates, CEO of Abingdon Health commented:

“I am delighted to welcome Olly Gardner to the Abingdon Health team. Olly’s expertise in change management and people strategy will be invaluable in supporting our exciting growth ambitions as we continue to rapidly expand our business to meet a significant increased demand for rapid testing service.”

Olly Gardner commented:

“I couldn’t be more delighted to join Abingdon Health at this very exciting stage of their growth. It is such an honour to be at the heart of the fight against COVID-19 and I can’t wait to roll out our UK-RTC antibody test over the coming months. Then, over the next few years, I look forward to working with our brilliant team to become the number one rapid testing company across the world.”

About Abingdon Health

Abingdon Health vision is to innovate to preserve and improve life.

We pursue this vision through using our rapid testing expertise to support our customers taking their projects through development and into high-throughput automated manufacturing. We focus on operational excellence to provide our customer with efficient, effective, automated and scalable development and manufacturing to support their ambitious plans and objectives.

Abingdon Health is headquartered in York, UK, with sites in both York, Doncaster and Birmingham.